Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
MARINUS PHARMACEUTICALS, INC. (MRNS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| 683 Capital Management, LLC reports a 0.2% stake in Marinus Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Lion Point Capital, LP reports a 9.9% stake in Marinus Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 0% stake in MARINUS PHARMACEUTICALS, INC. |
| 02/14/2022 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 7.8% stake in Marinus Pharmaceuticals, Inc. |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2022 |
SC 13G/A
| SUVRETTA CAPITAL MANAGEMENT, LLC reports a 7.2% stake in Marinus Pharmaceuticals, Inc. |
| 02/11/2022 |
SC 13G/A
| Avoro Capital Advisors LLC reports a 8.8% stake in Marinus Pharmaceuticals, Inc. |
| 02/02/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 7.3% stake in Marinus Pharmaceuticals, Inc. |
| 02/16/2021 |
SC 13G/A
| Bain Capital Life Sciences Fund, L.P. reports a 3.6% stake in Marinus Pharmaceuticals, Inc. |
| 02/12/2021 |
SC 13G/A
| Lion Point Capital, LP reports a 12.2% stake in Marinus Pharmaceuticals, Inc. |
| 02/12/2021 |
SC 13G/A
| Avoro Capital Advisors LLC reports a 9.1% stake in Marinus Pharmaceuticals, Inc. |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Bain Capital Life Sciences Fund, L.P. reports a 6.2% stake in Marinus Pharmaceuticals, Inc. |
| 02/07/2020 |
SC 13G/A
| JENNISON ASSOCIATES LLC reports a 0% stake in Marinus Pharmaceuticals, Inc. |
| 02/06/2020 |
SC 13G/A
| PRUDENTIAL FINANCIAL INC reports a 0% stake in MARINUS PHARMACEUTICALS INC |
| 01/27/2020 |
SC 13G/A
| Granite Point Capital Management, L.P. reports a 3.1% stake in Marinus Pharmaceuticals, Inc. |
| 03/11/2019 |
SC 13G/A
| FRANKLIN RESOURCES INC reports a 4.4% stake in Marinus Pharmaceuticals, Inc. |
| 02/14/2019 |
SC 13G/A
| Bain Capital Life Sciences Fund, L.P. reports a 8.7% stake in Marinus Pharmaceuticals, Inc. |
| 02/01/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/23/2019 |
SC 13G/A
| Granite Point Capital Management, L.P. reports a 8.1% stake in Marinus Pharmaceuticals, Inc. |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| Flynn James E reports a 0% stake in Marinus Pharmaceuticals, Inc. |
| 02/13/2018 |
SC 13G/A
| SPHERA FUNDS MANAGEMENT LTD. reports a 0% stake in MARINUS PHARMACEUTICALS, INC. |
| 01/11/2018 |
SC 13G/A
| Granite Point Capital Management, L.P. reports a 5.6% stake in Marinus Pharmaceuticals, Inc. |
| 01/10/2018 |
SC 13G/A
| FRANKLIN RESOURCES INC reports a 5.3% stake in MARINUS PHARMACEUTICALS, INC. |
| 12/19/2017 |
SC 13G/A
| Bain Capital Life Sciences Fund, L.P. reports a 8.9% stake in Marinus Pharmaceuticals, Inc. |
| 02/13/2017 |
SC 13G/A
| SPHERA FUNDS MANAGEMENT LTD. reports a 6.8% stake in MARINUS PHARMACEUTICALS, INC. |
| 08/22/2016 |
SC 13G/A
| Canaan VII LP reports a 4.4% stake in Marinus Pharmaceuticals, Inc. |
|
|